Steve Brozak Wants MASP-2 Targeting for COVID 19 Treatment
Steve Brozak is the Managing Partner and President of WBB Securities and is a Wall Street Journal’s “Best on the Street” analyst.
Stay updated with breaking news from Wall Street Transcript. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Steve Brozak is the Managing Partner and President of WBB Securities and is a Wall Street Journal’s “Best on the Street” analyst.
The current status of Mesoblast Limited (NASDAQ:MESO) allogeneic cell therapy in an interview with the CEO Silviu Itescu.
Chardan Analyst Geulah Livshits, PhD, picks the top gene therapy stocks to buy for investors for 2021 and beyond.
Autolus Therapeutics (NASDAQ:AUTL) is a Top Pick from William Blair's Matt Phipps, Ph.D., the StarMine No.1 biotechnology earnings estimator
John Heffern is Principal and Founder of KCA/Princeton Advisors. His career includes nearly 30 years of senior level portfolio management.